Omeros (OMER) has had the lowest return since January 1, 2025 by a small-cap US stock in the Pharmaceuticals Industry, returning -53.5%.
| ASSET | % RETURN |
|---|---|
Omeros (OMER) | -53.5% |
Canopy Growth (CGC) | -51.76% |
Arvinas (ARVN) | -50.82% |
Wave Life Sciences (WVE) | -42.8% |
Evolus (EOLS) | -41.49% |
Amphastar P (AMPH) | -28.42% |
Contineum Therapeutics, Inc Class A Common Stock (CTNM) | -23.47% |
Harmony Biosciences (HRMY) | -20.93% |
Enliven Therapeutics (ELVN) | -13.99% |
Septerna, Inc Common Stock (SEPN) | -10.98% |
Innoviva (INVA) | 0.06% |
Collegium Pharmaceutical (COLL) | 19.55% |
Tilray (TLRY) | 20% |
Cronos (CRON) | 28.36% |
Pacira BioSciences (PCRX) | 30.39% |
Aurora Cannabis (ACB) | 32.01% |
Harrow Health (HROW) | 33.81% |
CorMedix (CRMD) | 39.14% |
Avadel Pharmaceuticals (AVDL) | 42.41% |
SNDL (SNDL) | 44.94% |
Terns Pharmaceuticals (TERN) | 45.92% |
Eton Pharmaceuticals (ETON) | 48.73% |
Phathom Pharmaceuticals (PHAT) | 49.27% |
Theravance Biopharma (TBPH) | 52.33% |
Scpharmaceuticals (SCPH) | 57.5% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
